Delivery Order SPE2DB24D2102-SPE2DB25FJJGF
- Not listed
- The Defense Logistics Agency awarded a $14,879.31 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,148.50 for 90-tablet supplies of Gemtesa 75 mg tablets under a firm fixed-price contract. The award, made on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded, non-set-aside procurement. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $18,840.51 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $66,466.00 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on September 27, 2025, with completion targeted for September 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,533.50 to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Gemtesa 75 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with a completion date of November 19, 2025, and performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical delivery under the agency's medical supply procurement...
- The Defense Logistics Agency awarded a delivery order valued at $10,547.35 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count). The contract was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, and carries a firm fixed price structure with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $14,499.03 for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its...
- The Defense Logistics Agency awarded a delivery order valued at $14,891.75 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price contract is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $37,071.79 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Gemtesa 75 mg tablets (90-count units), with completion scheduled for October 30, 2025. The contract employs firm fixed pricing with no small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 90 tablets of Gemtesa 75 mg, with a ceiling value of $5,400.07 under a firm fixed-price delivery order contract. The award was competitively procured with no set-aside designation and is scheduled for completion by September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB25FJJGFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,178.07 to AmerisourceBergen Drug Corp for 90-tablet supplies of Gemtesa 75 mg tablets. This contract, awarded on June 17, 2025, with completion scheduled for June 18, 2025, was competitively procured without set-aside restrictions under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and extending through December 2026. This prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent capability in fulfilling military and veteran healthcare pharmaceutical needs across multiple therapeutic domains, with delivery orders typically structured as firm fixed-price arrangements ranging from minimal to substantial order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 6/17/25 |